Peter Pollak and Andrew Badrot, CMS Pharma || October 9, 2013 Review the business development cycle in the custom manufacturing industry and assess risks associated with pharmaceutical fine chemicals manufacturing
Andrew Badrot || June 1, 2011 China Vs. India in the API Race?
Andrew Badrot, CMS Pharma
Separating the noteworthy news from the noise is not always as straightforward as one may think. And sometimes, two separate newsfeeds get a new meaning when pieced together. Let me expla…